|
rdf:type |
|
|
lifeskim:mentions |
|
|
pubmed:issue |
3
|
|
pubmed:dateCreated |
2007-6-26
|
|
pubmed:abstractText |
Stavudine (d4T)-containing regimens are associated with a potential for lipoatrophy and dyslipidaemia. We assessed the safety and efficacy of reducing the dose of stavudine compared with switching to tenofovir or maintaining the standard dose of d4T.
|
|
pubmed:language |
eng
|
|
pubmed:journal |
|
|
pubmed:citationSubset |
IM
|
|
pubmed:chemical |
|
|
pubmed:status |
MEDLINE
|
|
pubmed:issn |
1359-6535
|
|
pubmed:author |
pubmed-author:ArnaizJoan AJA,
pubmed-author:BlancoJosé LJL,
pubmed-author:GarrabouGloriaG,
pubmed-author:GatellJosé MJM,
pubmed-author:LópezSoniaS,
pubmed-author:LagunoMontserratM,
pubmed-author:LarrousseMariaM,
pubmed-author:LeonAgatheA,
pubmed-author:LoncaMontserratM,
pubmed-author:MallolasJosepJ,
pubmed-author:MartinezEstebanE,
pubmed-author:MilinkovicAnaA,
pubmed-author:MiróOscarO,
pubmed-author:VidalSergiS,
pubmed-author:de LazzariElisaE
|
|
pubmed:issnType |
Print
|
|
pubmed:volume |
12
|
|
pubmed:owner |
NLM
|
|
pubmed:authorsComplete |
Y
|
|
pubmed:pagination |
407-15
|
|
pubmed:meshHeading |
pubmed-meshheading:17591031-Adenine,
pubmed-meshheading:17591031-Adult,
pubmed-meshheading:17591031-Anti-HIV Agents,
pubmed-meshheading:17591031-Body Composition,
pubmed-meshheading:17591031-Cholesterol,
pubmed-meshheading:17591031-Drug Administration Schedule,
pubmed-meshheading:17591031-Female,
pubmed-meshheading:17591031-HIV,
pubmed-meshheading:17591031-HIV Infections,
pubmed-meshheading:17591031-Humans,
pubmed-meshheading:17591031-Leukocytes, Mononuclear,
pubmed-meshheading:17591031-Lipodystrophy,
pubmed-meshheading:17591031-Male,
pubmed-meshheading:17591031-Middle Aged,
pubmed-meshheading:17591031-Mitochondria,
pubmed-meshheading:17591031-Oxygen Consumption,
pubmed-meshheading:17591031-Phosphonic Acids,
pubmed-meshheading:17591031-Stavudine,
pubmed-meshheading:17591031-Treatment Outcome,
pubmed-meshheading:17591031-Triglycerides
|
|
pubmed:year |
2007
|
|
pubmed:articleTitle |
The impact of reducing stavudine dose versus switching to tenofovir on plasma lipids, body composition and mitochondrial function in HIV-infected patients.
|
|
pubmed:affiliation |
Infectious Diseases Unit, Hospital Clinic Barcelona, Barcelona, Spain. anamilinkovic@hotmail.com
|
|
pubmed:publicationType |
Journal Article,
Clinical Trial,
Comparative Study,
Randomized Controlled Trial,
Research Support, Non-U.S. Gov't
|
